Immunotherapy for breast cancer: Is it feasible?

Leisha A. Emens, Vincent K. Tuohy, Sasha E. Stanton

Research output: Contribution to journalComment/debatepeer-review

Abstract

Immunotherapy invited leading experts in the field to share their thoughts on two key immunotherapeutic strategies in the field of breast cancer research, vaccines and checkpoint inhibitors. Interviewed by Ellen Clarke (Commissioning Editor, Future Science Group). Historically breast cancer has been considered immunologically silent. Patients have had limited access to the types of immunotherapy available to melanoma and lung cancer patients, but this could all be set to change as recent preclinical and clinical studies have highlighted the potential of immunotherapy for breast cancer. Breast cancer is now one of the major cancer types for which new immune-based treatments are being developed.

Original languageEnglish (US)
Pages (from-to)1135-1143
Number of pages9
JournalImmunotherapy
Volume7
Issue number11
DOIs
StatePublished - Nov 2015

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology

Fingerprint

Dive into the research topics of 'Immunotherapy for breast cancer: Is it feasible?'. Together they form a unique fingerprint.

Cite this